2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
11
Osteoporosis
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Colonic Neoplasms
5
Neoplasms
4
Obesity
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Inflammation
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bone Diseases, Metabolic
3
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Leukemia
2
Leiomyoma
2
Giant Cell Tumor of Bone
2
Gastrointestinal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Bone Diseases
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Data Collection
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Blood Specimen Collection
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
human papillomavirus vaccine, L1 type 16, 18
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
apremilast
1
Watchful Waiting
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
Vitamin D
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts